Piramal Enterprises gains on selling BST-CarGel to Smith & Nephew

13 Jan 2016 Evaluate

Piramal Enterprises is currently trading at Rs. 940.00, up by 6.05 points or 0.65% from its previous closing of Rs. 933.95 on the BSE.

The scrip opened at Rs. 940.00 and has touched a high and low of Rs. 940.00 and Rs. 940.00 respectively.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1043.00 on 20-May-2015 and a 52 week low of Rs. 805.00 on 18-Sep-2015.

Last one week high and low of the scrip stood at Rs. 995.00 and Rs. 926.10 respectively. The current market cap of the company is Rs. 16,220.00 crore.

The promoters holding in the company stood at 52.82% while Institutions and Non-Institutions held 30.91% and 16.27% respectively.

Piramal Enterprises has sold BST-CarGel from Piramal Healthcare (Canada), based in Montreal, Canada to Smith & Nephew, the global medical technology business. BST-CarGel is a first-line cartilage repair product used along with microfracture and other bone marrow stimulation techniques for the initial treatment of most sizes of focal cartilage tears. Through this transaction, an affiliate of Smith & Nephew plc will acquire ownership of all product and intellectual property assets related to BST-CarGel.

Piramal Enterprises is one of the leading players globally in CRAMS (custom research and manufacturing services) as well as in the critical care segment of inhalation and injectable anaesthetics. It also has a strong presence in the OTC segment in India.


Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 997.60
Shriram Finance 955.35
Aditya Birla Capital 346.80
Chola Invest & Fin. 1698.35
Tata Capital 337.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×